Literature DB >> 15101024

Albuminuria as a predictor of heart failure hospitalizations in patients with type 2 diabetes.

Melinda L Hockensmith1, Raymond O Estacio, Philip Mehler, Edward P Havranek, S Tevfik Ecder, Rita A Lundgren, Robert W Schrier.   

Abstract

BACKGROUND: Heart failure (HF) occurs more frequently and is a significant cause of mortality in diabetic patients. The purpose of the current study is to ascertain risk factors that are predictive of HF hospitalizations in type 2 diabetic patients.
METHODS: Longitudinal observational study of type 2 diabetic patients with baseline diastolic blood pressures > or =80 mm Hg and no history of New York Heart Association class III-IV HF or a serum creatinine > or =2.5 mg/dL nested within a randomized clinical trial. The outcome measure of this study was the first occurrence of HF hospitalization over a 5-year follow-up period.
RESULTS: Patients with overt albuminuria at baseline had a higher and earlier occurrence of HF hospitalizations than those with micro- or normoalbuminuria (13.6% versus 3.3%, odds ratio [OR]=3.1, 95% confidence interval [CI]=2.15-4.60, P<.0001). In the multiple logistic regression analyses, the presence of overt albuminuria (OR 5.4, 95% CI=2.3-12.5, P<.001), history of myocardial infarction (OR 4.6, 95% CI=1.6-13.1, P=.004) and a history of New York Heart Association Class I or II HF (OR 8.0, 95% CI=2.2-28.6, P=.0014) at baseline were independently associated with HF hospitalizations.
CONCLUSIONS: Overt albuminuria predicts the occurrence of HF hospitalizations in type 2 diabetic patients. Thus early aggressive treatment of diabetic nephropathy should be investigated as a means of preventing of HF.

Entities:  

Mesh:

Year:  2004        PMID: 15101024     DOI: 10.1016/j.cardfail.2003.09.003

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  5 in total

1.  Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial.

Authors:  Benjamin M Scirica; Ofri Mosenzon; Deepak L Bhatt; Jacob A Udell; Ph Gabriel Steg; Darren K McGuire; KyungAh Im; Estella Kanevsky; Christina Stahre; Mikaela Sjöstrand; Itamar Raz; Eugene Braunwald
Journal:  JAMA Cardiol       Date:  2018-02-01       Impact factor: 14.676

2.  Diminished renal function and the incidence of heart failure.

Authors:  Johan Arnlöv
Journal:  Curr Cardiol Rev       Date:  2009-08

3.  Changes in diastolic dysfunction in diabetes mellitus over time.

Authors:  Aaron M From; Christopher G Scott; Horng H Chen
Journal:  Am J Cardiol       Date:  2009-04-01       Impact factor: 2.778

4.  Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 diabetes mellitus.

Authors:  Xilin Yang; Ronald C Ma; Wing-Yee So; Alice P Kong; Gary T Ko; Chun-Shun Ho; Christopher W Lam; Clive S Cockram; Peter C Tong; Juliana C Chan
Journal:  Cardiovasc Diabetol       Date:  2008-04-22       Impact factor: 9.951

Review 5.  Type 2 Diabetes and Heart Failure: Challenges and Solutions.

Authors:  Merlin C Thomas
Journal:  Curr Cardiol Rev       Date:  2016
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.